In‐hospital outcomes among amyloidosis patients with atrial fibrillation: A propensity score‐matched analysis-Reference-Cited by-同舟云学术

In‐hospital outcomes among amyloidosis patients with atrial fibrillation: A propensity score‐matched analysis

Published:2024-06-18 Issue:4 Volume:40 Page:1001-1004
ISSN:1880-4276
Container-title:Journal of Arrhythmia
language:en
Short-container-title:Journal of Arrhythmia

Author:

Yeo Yong‐Hao¹^ORCID,San Boon‐Jian²,Ang Qi‐Xuan³,Tan Min‐Choon⁴⁵,Tan Jian Liang⁶

Affiliation:

1. Department of Internal Medicine‐Pediatrics Corewell Health William Beaumont University Hospital Royal Oak Michigan USA

2. Department of Internal Medicine Jacobi Medical Center/Albert Einstein College of Medicine Bronx New York USA

3. Department of Internal Medicine Sparrow Health System and Michigan State University East Lansing Michigan USA

4. Department of Internal Medicine New York Medical College at Saint Michael's Medical Center Newark New Jersey USA

5. Department of Cardiovascular Medicine Mayo Clinic Phoenix Arizona USA

6. Electrophysiology Section, Hospital of the University of Pennsylvania Philadelphia Pennsylvania USA

Abstract

AbstractBackgroundThe impact of atrial fibrillation (AF) among patients with amyloidosis on in‐hospital outcomes is not well‐established. We aimed to examine in‐hospital outcomes among patients admitted with a primary diagnosis of AF with and without amyloidosis.Methods and ResultsWe queried the Nationwide Readmissions Database to compare the in‐hospital outcomes among AF patients with and without amyloidosis. Our study demonstrated that in‐hospital all‐cause mortality, adverse events, and 30‐day readmission were comparable between the two groups.ConclusionsPatients with AF and concurrent amyloidosis did not have worse in‐hospital outcomes than those with AF alone.

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/joa3.13100

Reference5 articles.

1. Light chain amyloidosis: Where are the light chains from and how they play their pathogenic role?

2. Management of Arrhythmias in Cardiac Amyloidosis

3. Novel strategies for the diagnosis and treatment of cardiac amyloidosis

4. Transthyretin (TTR) Cardiac Amyloidosis

5. Clinical features and predictors of atrial fibrillation in patients with light‐chain or transthyretin cardiac amyloidosis